Home › Companies › FULCRUM THERAPEUTICS INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and FULCRUM THERAPEUTICS INC.’s Form 8-K, filed June 27, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 26, 2025: 5 items on FULCRUM THERAPEUTICS INC.’s Form 8-K, filed June 27, 2025: 2 approved · 3 passed (calculated).
Significant dissent: 1 director (28.2% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2024-2025 2025-2026
Activist investors: Tang Capital (13F, 9.3%, as of September 30, 2026) · Nantahala Capital (13F, 8.6%, as of September 30, 2026)
Explore FULCRUM THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are FULCRUM THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 27, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Katina Dorton | 44,618,582 | -- | -- | 1,601,489 | 3,317,555 | 97% | Passed (calculated) | — |
| Elect Director: Robert J. Gould | 43,847,378 | -- | -- | 2,372,693 | 3,317,555 | 95% | Passed (calculated) | — |
| Elect Director: Kate Haviland | 33,203,495 | -- | -- | 13,016,576 | 3,317,555 | 72% | Passed (calculated) | — |
| Fulcrum's stockholders approved, on a non-binding advisory basis, the compensation of Fulcrum's named executive officers. | 46,099,800 | 111,967 | 8,304 | -- | 3,317,555 | 99.8% | Approved | — |
| Fulcrum's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2025. The results of the stockholders' vote with respect to such ratification are | 49,513,190 | 22,808 | 1,628 | -- | 0 | 99.9% | Approved | — |
Source: FULCRUM THERAPEUTICS INC., Form 8-K, filed with the SEC on June 27, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
125 asset managers disclosed a vote on at least one FULCRUM THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of FULCRUM THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
72% Majority: yes · of votes cast
Description as filed by funds: Election Class III Directors, nominated by our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Kate Haviland
FULCRUM THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kate Haviland”): 33,203,495 for, 13,016,576 withheld, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 72% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 1,436,899 for, 6,420,594 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 3,265,334 | Withhold |
| BlackRock | 173,098 | 0 | 0 | 1,634,588 | Mixed |
| Fidelity | 1,082,655 | 0 | 0 | 45,000 | For |
| Charles Schwab | 0 | 0 | 0 | 383,951 | Withhold |
| Aberdeen | 0 | 0 | 0 | 228,320 | Withhold |
| Equitable | 0 | 0 | 0 | 168,411 | Withhold |
| TIAA | 152,992 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 124,902 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 108,026 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 65,323 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 48,242 | Withhold |
| Invesco | 0 | 0 | 0 | 45,343 | Withhold |
| Northern Trust | 0 | 0 | 0 | 40,161 | Withhold |
| Global X | 0 | 0 | 0 | 31,932 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 28,209 | Withhold |
| Pacific Life | 0 | 0 | 0 | 23,865 | Withhold |
| John Hancock | 0 | 0 | 0 | 22,562 | Withhold |
| Bridge Builder Trust | 0 | 0 | 0 | 21,498 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 19,002 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 18,548 | Withhold |
| PACE SELECT ADVISORS TRUST | 0 | 0 | 0 | 16,282 | Withhold |
| Jackson National | 0 | 0 | 0 | 14,631 | Withhold |
| Prudential/PGIM | 0 | 0 | 0 | 11,430 | Withhold |
| ProShares | 0 | 0 | 0 | 10,775 | Withhold |
| AQR | 0 | 0 | 0 | 10,274 | Withhold |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election Class III Directors, nominated by our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Katina Dorton
FULCRUM THERAPEUTICS INC.’s own tally for this item (“Elect Director: Katina Dorton”): 44,618,582 for, 1,601,489 withheld, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 7,750,334 for, 107,159 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,265,334 | 0 | 0 | 0 | For |
| BlackRock | 1,807,686 | 0 | 0 | 0 | For |
| Fidelity | 1,127,655 | 0 | 0 | 0 | For |
| Charles Schwab | 383,951 | 0 | 0 | 0 | For |
| Aberdeen | 228,320 | 0 | 0 | 0 | For |
| Equitable | 98,521 | 0 | 0 | 69,890 | Mixed |
| TIAA | 152,992 | 0 | 0 | 0 | For |
| American Century | 124,902 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,026 | 0 | 0 | 0 | For |
| Goldman Sachs | 65,323 | 0 | 0 | 0 | For |
| Lincoln Financial | 38,200 | 0 | 0 | 10,042 | Mixed |
| Invesco | 45,343 | 0 | 0 | 0 | For |
| Northern Trust | 40,161 | 0 | 0 | 0 | For |
| Global X | 31,932 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 28,209 | 0 | 0 | 0 | For |
| Pacific Life | 23,865 | 0 | 0 | 0 | For |
| John Hancock | 22,562 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,498 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 19,002 | 0 | 0 | 0 | For |
| Voya | 18,548 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 16,282 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 14,631 | Withhold |
| Prudential/PGIM | 0 | 0 | 0 | 11,430 | Withhold |
| ProShares | 10,775 | 0 | 0 | 0 | For |
| AQR | 10,274 | 0 | 0 | 0 | For |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election Class III Directors, nominated by our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Robert J. Gould
FULCRUM THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert J. Gould”): 43,847,378 for, 2,372,693 withheld, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 7,706,625 for, 150,868 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,265,334 | 0 | 0 | 0 | For |
| BlackRock | 1,807,686 | 0 | 0 | 0 | For |
| Fidelity | 1,127,655 | 0 | 0 | 0 | For |
| Charles Schwab | 383,951 | 0 | 0 | 0 | For |
| Aberdeen | 228,320 | 0 | 0 | 0 | For |
| Equitable | 98,521 | 0 | 0 | 69,890 | Mixed |
| TIAA | 152,992 | 0 | 0 | 0 | For |
| American Century | 124,902 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,026 | 0 | 0 | 0 | For |
| Goldman Sachs | 65,323 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 48,242 | Withhold |
| Invesco | 45,343 | 0 | 0 | 0 | For |
| Northern Trust | 40,161 | 0 | 0 | 0 | For |
| Global X | 31,932 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 28,209 | 0 | 0 | 0 | For |
| Pacific Life | 23,865 | 0 | 0 | 0 | For |
| John Hancock | 22,562 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,498 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 19,002 | 0 | 0 | 0 | For |
| Voya | 18,548 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 16,282 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 0 | 14,631 | Withhold |
| Prudential/PGIM | 0 | 0 | 0 | 11,430 | Withhold |
| ProShares | 10,775 | 0 | 0 | 0 | For |
| AQR | 10,274 | 0 | 0 | 0 | For |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
99.8% Approved · of votes cast
Description as filed by funds: A non-binding advisory vote on executive compensation;
FULCRUM THERAPEUTICS INC.’s own tally for this item (“Fulcrum's stockholders approved, on a non-binding advisory basis, the compensation of Fulcrum's named executive officers.”): 46,099,800 for, 111,967 against — passed, per its Form 8-K filed June 27, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “b) Fulcrum's stockholders approved, on a non-binding advisory basis, the compensation of Fulcrum's named executive officers.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,265,334 | 0 | 0 | 0 | For |
| BlackRock | 1,807,686 | 0 | 0 | 0 | For |
| Fidelity | 1,127,655 | 0 | 0 | 0 | For |
| Charles Schwab | 383,951 | 0 | 0 | 0 | For |
| Aberdeen | 228,320 | 0 | 0 | 0 | For |
| Equitable | 168,411 | 0 | 0 | 0 | For |
| TIAA | 152,992 | 0 | 0 | 0 | For |
| American Century | 124,902 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,026 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 80,294 | 0 | 0 | 0 | For |
| Goldman Sachs | 65,323 | 0 | 0 | 0 | For |
| Lincoln Financial | 48,242 | 0 | 0 | 0 | For |
| Invesco | 45,343 | 0 | 0 | 0 | For |
| Northern Trust | 40,161 | 0 | 0 | 0 | For |
| Global X | 31,932 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 28,209 | 0 | 0 | 0 | For |
| Pacific Life | 23,865 | 0 | 0 | 0 | For |
| John Hancock | 22,562 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,498 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 19,002 | 0 | 0 | 0 | For |
| Voya | 18,548 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 16,282 | 0 | 0 | 0 | For |
| Jackson National | 14,631 | 0 | 0 | 0 | For |
| Prudential/PGIM | 11,430 | 0 | 0 | 0 | For |
| ProShares | 10,775 | 0 | 0 | 0 | For |
Fund voting reports, all 43 managers: 7,936,621 for, 1,166 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9,332,719 | 0 | 0 | 0 | For |
| TCG Crossover Management, LLC | 5,250,000 | 0 | 0 | 0 | For |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,223,879 | 0 | 0 | 0 | For |
| Nantahala Capital Management, LLC | 4,306,473 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,376,528 | 0 | 0 | 0 | For |
| BlackRock | 1,729,021 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,217,603 | 0 | 0 | 0 | For |
| Woodline Partners LP | 897,617 | 0 | 0 | 0 | For |
| State Street | 880,119 | 0 | 0 | 0 | For |
| Exome Asset Management LLC | 622,887 | 0 | 0 | 0 | For |
| BESSEMER TRUST Co NATIONAL ASSOCIATION | 574,951 | 0 | 0 | 0 | For |
| ADAR1 Capital Management, LLC | 447,673 | 0 | 0 | 0 | For |
| Charles Schwab | 383,951 | 0 | 0 | 0 | For |
| DE Shaw | 355,193 | 0 | 0 | 0 | For |
| Bessemer Trust CO of Delaware, N.A. | 292,760 | 0 | 0 | 0 | For |
| BESSEMER TRUST CO | 289,237 | 0 | 0 | 0 | For |
| BESSEMER TRUST Co OF FLORIDA | 289,237 | 0 | 0 | 0 | For |
| Bessemer Trust Co of Nevada, National Association | 289,237 | 0 | 0 | 0 | For |
| Northern Trust | 253,963 | 0 | 0 | 0 | For |
| Aberdeen | 228,320 | 0 | 0 | 0 | For |
| Citadel | 223,623 | 0 | 0 | 0 | For |
| Catalio Capital Management, LP | 188,304 | 0 | 0 | 0 | For |
| Dimensional | 187,464 | 0 | 0 | 0 | For |
| Nuveen | 152,992 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 151,347 | 0 | 0 | 0 | For |
Institutional-manager reports, all 98 managers: 37,645,584 for, 17,917 against, 24,025 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: A non-binding advisory vote on the frequency of future executive compensation advisory votes; and
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Aberdeen | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| PACE SELECT ADVISORS TRUST | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
| Prudential/PGIM | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| AQR | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 42 managers: 7,821,390 1 year, 36,103 3 year. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 0 | 0 | 0 | 0 | -- |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Woodline Partners LP | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| BESSEMER TRUST Co NATIONAL ASSOCIATION | 0 | 0 | 0 | 0 | -- |
| ADAR1 Capital Management, LLC | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| DE Shaw | 0 | 0 | 0 | 0 | -- |
| Bessemer Trust CO of Delaware, N.A. | 0 | 0 | 0 | 0 | -- |
| BESSEMER TRUST CO | 0 | 0 | 0 | 0 | -- |
| BESSEMER TRUST Co OF FLORIDA | 0 | 0 | 0 | 0 | -- |
| Bessemer Trust Co of Nevada, National Association | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Aberdeen | 0 | 0 | 0 | 0 | -- |
| Citadel | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| FIDUCIARY TRUST CO | 0 | 0 | 0 | 0 | -- |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| Matisse Capital | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 91 managers: 27,134 for, 386 against, 24,665,541 1 year, 187,464 3 year. Showing the 25 largest; every one is in the interactive database (link above).
99.9% Approved · of votes cast
Prior year: 100.0% for (June 17, 2024 meeting) unchanged
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
FULCRUM THERAPEUTICS INC.’s own tally for this item (“Fulcrum's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2025. The results of the stockholders' vote with respect to ”): 49,513,190 for, 22,808 against — passed, per its Form 8-K filed June 27, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Fulcrum's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 7,856,327 for, 1,166 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,265,334 | 0 | 0 | 0 | For |
| BlackRock | 1,807,686 | 0 | 0 | 0 | For |
| Fidelity | 1,127,655 | 0 | 0 | 0 | For |
| Charles Schwab | 383,951 | 0 | 0 | 0 | For |
| Aberdeen | 228,320 | 0 | 0 | 0 | For |
| Equitable | 168,411 | 0 | 0 | 0 | For |
| TIAA | 152,992 | 0 | 0 | 0 | For |
| American Century | 124,902 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,026 | 0 | 0 | 0 | For |
| Goldman Sachs | 65,323 | 0 | 0 | 0 | For |
| Lincoln Financial | 48,242 | 0 | 0 | 0 | For |
| Invesco | 45,343 | 0 | 0 | 0 | For |
| Northern Trust | 40,161 | 0 | 0 | 0 | For |
| Global X | 31,932 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 28,209 | 0 | 0 | 0 | For |
| Pacific Life | 23,865 | 0 | 0 | 0 | For |
| John Hancock | 22,562 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,498 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 19,002 | 0 | 0 | 0 | For |
| Voya | 18,548 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 16,282 | 0 | 0 | 0 | For |
| Jackson National | 14,631 | 0 | 0 | 0 | For |
| Prudential/PGIM | 11,430 | 0 | 0 | 0 | For |
| ProShares | 10,775 | 0 | 0 | 0 | For |
| AQR | 10,274 | 0 | 0 | 0 | For |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 53,979,306 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 6.05% |
| 2 | BlackRock | 3.35% |
| 3 | Fidelity | 2.09% |
| 4 | Charles Schwab | 0.71% |
| 5 | Aberdeen | 0.42% |
| 6 | Equitable | 0.31% |
| 7 | TIAA | 0.28% |
| 8 | American Century | 0.23% |
| 9 | QUANTITATIVE MASTER SERIES LLC | 0.20% |
| 10 | Simplify Exchange Traded Funds | 0.15% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 17.29% |
| 2 | TCG Crossover Management, LLC | 9.73% |
| 3 | SUVRETTA CAPITAL MANAGEMENT, LLC | 9.68% |
| 4 | Nantahala Capital Management, LLC | 7.98% |
| 5 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.40% |
| 6 | BlackRock | 3.20% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.26% |
| 8 | Woodline Partners LP | 1.66% |
| 9 | State Street | 1.63% |
| 10 | Exome Asset Management LLC | 1.15% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| RA Capital Management, L.P. | 10,229,099 | 18.95% | Proxy statement (DEF 14A), proxy filed April 30, 2025 |
| TCG Crossover GP II, LLC | 5,250,000 | 9.73% | Schedule 13G, filed May 15, 2026 |
| BlackRock | 4,710,697 | 8.73% | Form 13F, quarter ended March 31, 2025 |
| Suvretta Capital Management, LLC | 3,404,612 | 6.31% | Proxy statement (DEF 14A), proxy filed April 30, 2025 |
| Vanguard Group | 3,220,378 | 5.97% | Form 13F, quarter ended March 31, 2025 |
| Nantahala Capital Management, LLC | 3,050,040 | 5.65% | Schedule 13G, filed May 15, 2026 |
| Adage Capital Partners GP, LLC. | 3,000,000 | 5.56% | Proxy statement (DEF 14A), proxy filed April 30, 2025 |
| Adage Capital Management, L.P. | 2,432,000 | 4.51% | Schedule 13G, filed November 13, 2025 |
| Dimensional Fund Advisors | 1,407,049 | 2.61% | Form 13F, quarter ended March 31, 2025 |
| Alex C. Sapir | 1,296,449 | 2.40% | Proxy statement (DEF 14A), proxy filed April 30, 2025 |
Percentages above are of 53,979,306 shares outstanding, as reported by FULCRUM THERAPEUTICS INC. on its Form 10-Q dated April 24, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At FULCRUM THERAPEUTICS INC.'s shareholder meeting held June 26, 2025, in the 2024-2025 proxy season, 125 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 968 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — A non-binding advisory vote on executive compensation; — FULCRUM THERAPEUTICS INC.'s filing reports the proposal as approved, with 99.8% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: FULCRUM THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 27, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from FULCRUM THERAPEUTICS INC.’s 10-Q dated April 24, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
FULCRUM THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “FULCRUM THERAPEUTICS (FULC) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/fulcrum-therapeutics-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.